Le Lézard
Classified in: Health

Spinal Surgeon, Dr. Justin P. Kubeck of Ocean Orthopedic Associates Named NJ Top Doc


SCOTCH PLAINS, N.J., March 27, 2020 /PRNewswire-PRWeb/ -- Justin P. Kubeck, MD of Ocean Orthopedic Associates has been reviewed and approved by NJ Top Docs. Dr. Kubeck has been approved every year consecutively since 2016. Dr. Kubeck is board certified by the American Board of Orthopaedic Surgery and specializes in Spinal Surgery.

Dr. Kubeck's medical education began at Thomas Jefferson University. He then completed his Internship and Residency at the University Hospital of Brooklyn. His Fellowship was then completed at the University of California.

Currently, Dr. Kubeck is affiliated with the following hospitals:

To learn more about Dr. Kubeck, please visit: https://njtopdocs.com/nj-doctors/ocean-orthopedic-associates/

About Us

NJ Top Docs is a comprehensive, trusted and exclusive healthcare resource featuring reviewed and approved Top Doctors and Dentists in New Jersey online in an easy to use format. NJ Top Docs only reviews and approves providers based on merit after they have been extensively vetted.

NJ Top Docs is a division of USA Top Docs which allows patients to meet providers online before making their appointment.

For more information, please click here to contact us or visit http://www.NJTopDocs.com.

You can also follow us on Facebook, Twitter, & Instagram.

 

SOURCE NJ Top Docs


These press releases may also interest you

at 11:23
Today, Samaritan's Purse deployed its Emergency Field Hospital to New York City, New York, where the local medical infrastructure is severely overwhelmed. In cooperation with the Federal Emergency Management Agency (FEMA), New York state officials,...

at 11:01
Novartis today announced results from a prespecified analysis of pooled data from three Phase III studies evaluating the safety and efficacy of inclisiran, its first-in-class investigational treatment for hyperlipidemia in adults. The data was...

at 11:00
As the impact of the Coronavirus (COVID-19) is now felt worldwide, we want to assure our customers and partners that we are still here to support you. Zenner's operations remain open with regular operating hours. Zenner's number one priority is...

at 10:13
The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the VOYAGER PAD study met its primary efficacy and principal safety endpoints, demonstrating the XARELTO® (rivaroxaban) vascular dose (2.5 mg twice daily) plus aspirin (100 mg...

at 10:05
Merck , known as MSD outside the United States and Canada, today announced the presentation of results from the VICTORIA trial, a Phase 3 study evaluating the efficacy and safety of its investigational drug vericiguat, an orally administered soluble...

at 10:00
Amgen today announced positive results from the EvolocumaB Effect on LDL-C LowerIng in SubJEcts with Human Immunodeficiency ViRus and INcreased Cardiovascular RisK (BEIJERINCK) study evaluating the efficacy and safety of Repatha® (evolocumab) in...



News published on 27 march 2020 at 03:00 and distributed by: